UNC Hospitals — Chapel Hill, North Carolina

Public research footprint of UNC Hospitals, compiled from the ClinicalTrials.gov public registry.

135

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Pulmonary Arterial Hypertension · EGF-R Positive Non-Small Cell Lung Cancer · Metastatic Lung Non-Small Cell Carcinoma · Relapsed/Refractory Multiple Myeloma

Recently updated registry entries

NCT07284758 — A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With… (Recruiting)
NCT06447168 — A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… (Recruiting)
NCT06274801 — Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UNC Hospitals?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.